🔴 Revvity is trading 4.6% down today after XLV ETF's 2.19% decline

Revvity is trading 4.6% down at $121.20 after a broad healthcare-sector selloff.

• The XLV ETF was down 2.19% during regular trading.
• Concerns include worsening U.S. health-insurance coverage, potential loss of ACA subsidies, and pressure on healthcare profitability.
• No fresh earnings release or major company-specific event appeared in September 9 morning headlines; Revvity’s scheduled Wells Fargo conference presentation was the main company event.